Skip to main content

Depo-Provera News

Related terms: Depo Injection, Depo, Depo Shot

Prolonged Use of Progestogens May Raise Risk for Intracranial Meningioma

FRIDAY, March 29, 2024 – Prolonged use of medrogestone, medroxyprogesterone acetate, and promegestone is associated with an increased risk for intracranial meningioma, according to a study published...

Hormonal Meds for Birth Control, Menopause Linked to Brain Tumors

THURSDAY, March 28, 2024 – The contraceptive injection Depo-Provera and two drugs used for menopause relief could be linked to a heightened risk for brain tumors in some women, a new study warns....

FDA Medwatch Alert: Olympia Pharmacy Sterile Compounded Products: Recall - Concerns About Sterility Assurance

  [Posted 05/30/2013] ISSUE: Lowlite Investments d/b/a Olympia Pharmacy ("Lowlite") notified the public of a voluntary multi-state recall of all sterile drug products compounded by the pharmacy that ...

FDA Medwatch Alert: Qualitest Pharmaceuticals Oral Contraceptives: Recall - Packaging Error

includes Cyclafem 7/7/7, Cyclafem 1/35, Emoquette, Gildess FE 1.5/30, Gildess FE 1/20, Orsythia, Previfem, Tri-Previfem ISSUE: Qualitest Pharmaceuticals issued a nationwide, retail-level recall of...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Contraception, Birth Control

Depo-Provera patient information at Drugs.com